Clinical pharmacists participating in the analysis of drug therapy for a case of Bartonella henselae meningitis

Published on Nov. 07, 2023Total Views: 1457 times Total Downloads: 564 times Download Mobile

Author: PENG Tingting ¹ YANG Ruixi ² NING Hong ¹  TIAN Yalan ¹

Affiliation: 1. Department of Pharmacy, Mianyang Hospital Affiliated to School of Medicine, University of Electronic Science and Technology of China · Mingyang Central Hospital, Mianyang 621000, Sichuan Province, China 2.Department of Infectious Diseases, Mianyang Hospital Affiliated to School of Medicine, University of Electronic Science and Technology of China · Mingyang Central Hospital, Mianyang 621000, Sichuan Province, China

Keywords: Bartonella henselae meningitis Anti-infective therapy Pharmaceutical care

DOI: 10.12173/j.issn.1005-0698.202305032

Reference: PENG Tingting, YANG Ruixi, NING Hong, TIAN Yalan.Clinical pharmacists participating in the analysis of drug therapy for a case of Bartonella henselae meningitis[J].Yaowu Liuxingbingxue Zazhi,2024, 33(1):106-110.DOI: 10.12173/j.issn.1005-0698.202305032.[Article in Chinese]  Copied

Abstract
Full-text
References

Abstract

Clinical pharmacists participated in the anti-infection treatment of a patient with Bartonella henselae meningitis. According to the clinical manifestations and the quantitative metagenomic second-generation sequencing (mNGS) of cerebrospinal fluid, the patient was diagnosed as Bartonella henselae infection. According to the relevant clinical guidelines and foreign case treatment reports, it is recommended to use minocycline hydrochloride capsule oral treatment combined with rifampicin injection. Follow-up treatment of the patient was dynamically adjusted based on the reexamination results of cerebrospinal fluid and related inflammatory indicators. In the treatment process, clinical pharmacists give full play to their professional expertise, provide the patient with individualized pharmaceutical care, optimize anti-infection programs, and further promote clinical rational drug use.

Full-text

Please download the PDF version to read the full text: download

References

1.Rodrigues CMC, Maiden MCJ. A world without bacterial meningitis: how genomic epidemiology can inform vaccination strategy[J]. F1000Res, 2018, 7: 401. DOI: 10.12688/f1000research.13793.1.

2.唐宇凤, 段劲峰, 冯由军. 成人不典型细菌性脑膜炎16例临床分析[J].实用医院临床杂志, 2013, 10(2): 111-113. [Tang YF, Duan JF, Feng YJ. Clinical analysis of 16 cases of atypical bacterial meningitis in adults[J].Practical Journal of Clinical Medicine, 2013, 10(2): 111-113.] DOI: 10.3969/j.issn.1672-6170.2013.02.039.

3.Kim KS. Human meningitis-associated escherichia coli[J]. EcoSal Plus, 2016, 7(1): 10. DOI: 10.1128/ecosalplus.ESP-0015-2015.

4.彭忠, 李春辉, 陈焕春, 等. 细菌性脑膜炎概述[J].中国感染控制杂志, 2022, 21(1): 97-103. [Peng Z, Li CH, Chen HC, et al. Overview of bacterial meningitis[J].Chinese Journal of Infection Control, 2022, 21(1): 97-103.]DOI: 10.12138/j.issn.1671-9638.20227920.

5.尚晶, 上官丽娟, 王燕宏, 等. 宏基因组二代测序法诊断细菌性脑膜炎的应用价值[J]. 中西医结合心脑血管病杂志, 2020, 18(15): 2545-2548. [Shang J, Shangguan LJ, Wang YH, et al. Application of metagenomic second-generation sequencing in the diagnosis of bacterial meningitis value[J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 2020, 18(15): 2545-2548.] DOI: 10.12102/j.issn.1672-1349.2020.15.043.

6.Okaro U, George S, Anderson B. What is in a cat scratch? growth of Bartonella henselae in a biofilm[J]. Microorganisms, 2021, 9(4): 835. DOI: 10.3390/microor ganisms9040835.

7.Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections[J]. Int J Antimicrob Agents, 2014, 44(1): 16-25. DOI: 10.1016/j.ijantimicag.2014.04.006.

8.Samarkos M, Antoniadou V, Vaiopoulos AG, et al. Encephalopathy in an adult with cat-scratch disease[J]. BMJ Case Rep, 2018, 2018: bcr2017223647. DOI: 10.1136/ bcr-2017-223647.

9.Wechtaisong W, Bonnet SI, Lien YY, et al. Transmission of Bartonella henselae within rhipicephalus sanguineus: data on the potential vector role of the tick[J]. PLoS Negl Trop Dis, 2020, 14(10): e8664. DOI: 10.1371/journal.pntd.0008664.

10.Angelakis E, Khamphoukeo K, Grice D, et al. Molecular detection of Bartonella species in rodents from the Lao PDR[J]. Clin Microbiol Infect, 2009, 15 Suppl 2: 95-97.DOI: 10.1111/j.1469-0691.2008.02177.x.

11.Biswas S, Rolain JM. Bartonella infection: treatment and drug resistance[J]. Future Microbiol, 2010, 5(11): 1719-1731. DOI: 10.2217/fmb.10.133.

12.李小丽, 阴赪宏. 对巴尔通体感染的临床认识[J]. 中国病原生物学杂志, 2012, 7(11): 872-875. [Li XL, Yin CH. Clinical understanding of Bartonella infection[J]. Journal of Pathogen Biology, 2012, 7(11): 872-875.] DOI: 10.13350/j.cjpb.2012.11.004.

13.Oray M, Onal S, Koc AA, et al. Diverse clinical signs of ocular involvement in cat scratch disease[J]. Turk J Ophthalmol, 2017, 47(1): 9-17. DOI: 10.4274/tjo.28009.

14.Li M, Yan K, Jia P, et al. Metagenomic next-generation sequencing may assist diagnosis of cat-scratch disease[J]. Front Cell Infect Microbiol, 2022, 12: 946849. DOI: 10.3389/fcimb.2022.946849.

15.戴维·吉尔伯特, 亨利·钱伯斯, 迈克尔·萨格, 等编著. 范洪伟, 主译.热病: 桑福德抗微生物治疗指南, 第50版[M]. 北京:中国协和医科大学出版社, 2021: 73.

16.Angibaud G, Balague JP, Lafontan JF. Bartonella hensalae encephalopathy[J]. Presse Med, 2005, 34(4): 297-298.DOI: 10.1016/s0755-4982(05)83910-7.

17.Cunha BA, Baron J, Cunha CB. Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations[J]. Eur J Clin Microbiol Infect Dis, 2018 , 37(1): 15-20. DOI: 10.1007/s10096-017-3081-x.

18.Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial[J]. Lancet Infect Dis, 2013, 13(1): 27-35. DOI: 10.1016/S1473-3099(12)70264-5.